MANILA, Philippines – The Department of Trade and Industry (DTI) on Friday clarified that no decision has been made regarding a proposal to allow sari-sari stores to sell over-the-counter (OTC) medicines.

In a statement, Trade Secretary Cristina A. Roque said the department acknowledges the concerns raised by stakeholders in the pharmaceutical and healthcare sectors, stressing that public health and safety remain a top priority.

“We are fully aware of the potential health risks associated with OTC drug products and the importance of ensuring their safe and responsible distribution,” Roque said.

She added that the proposal is still under evaluation and has not been finalized.

“The DTI does not proceed with any actions without proper consultation with all relevant stakeholders. We remain committed to ensuring that any future policy aligns with existing regulations, prioritizes public health and safety, and undergoes thorough review and consultation,” she said.

The statement comes amid public debate over the risks and benefits of expanding access to basic medications through neighborhood stores, especially in remote or underserved communities.

The DTI assured the public that all future actions will involve coordination with the Department of Health (DOH), Food and Drug Administration (FDA), and other relevant agencies.